The International Antiviral Society–USA Panel has released updated recommendations for the treatment and prevention of HIV infection in adults, as published in the Journal of the American Medical Association (media.jamanetwork.com). Michael Saag, MD, director of the University of …
July 2018
Gilead Announces Changes to Advancing Access Program
Gilead announced its committed to ensuring that people at risk of HIV have access to Truvada for PrEP (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg) tablets. Gilead supports comprehensive payer coverage and maintains the Gilead Advancing Access program …
IHIPC Recruiting New Members for 2019
Applications will be accepted until September 15
The Illinois HIV Integrated Planning Council (IHIPC) has officially opened up its recruitment for new members for 2019. The council seeks to fill six at-large non-voting member positions. Applications will be accepted until …
Free IHIPC Webinar Training on High-Impact HIV Prevention Now Posted
The annually updated “High Impact Prevention and Approved Prevention Strategies and Interventions” webinar training can be found directly at: http://www.ihipc.org/HIP&AHSI. The training is presented by Jeffery Erdman on behalf of the Illinois HIV Integrated Planning Council (IHIPC) Linkage to …
Northwestern’s EDIT Community Spotlight Podcast is Live
The Evaluation, Data Integration, and Technical Assistance (EDIT) Program housed in Northwestern University’s Institute for Sexual and Gender Minority Health and Wellbeing is starting a podcast called the EDIT Community Spotlight.
The podcast will feature a series of conversations with …
Help Test a HIV Prevention App for Young Men Age 13 to 18
The MyPEEPS Mobile Study at Ann & Robert H. Lurie Children’s Hospital of Chicago is looking for young guys age to 13 to 18 who are into other guys to help test a mobile HIV prevention app. Eligible individuals will …
ATEAM Looks for PrEP Study Participants
The ATEAM Study at the CORE Center of the Cook County Health and Hospital System is looking for assigned males at birth age 16 to 24 who are HIV-negative and interested in PrEP.
The ATEAM Study is a NIH-sponsored study …